Bruker Expects 25 Percent Revenue Growth for 2011 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — Bruker this morning reported that it expects to post $465 million in revenue for the fourth quarter of 2011 and $1.64 billion in revenue for the full year.

The company released the preliminary results in a filing with the US Securities and Exchange Commission ahead of a presentation at the JP Morgan Healthcare Conference in San Francisco later today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.